Monoamine oxidase inhibitor toxicity: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
* | *Mono Amine Oxidase Inhibitors | ||
*Lead to increased | *Used to treat depression and Parkinsonism (e.g. selegiline) | ||
*Toxicity often delayed 6- | *Lead to increased norepinephrine, serotonin, dopamine, tyramine | ||
*Toxicity often delayed 6-24 hours after ingestion | |||
==Clinical Features== | ==Clinical Features of Overdose== | ||
*Similar to | *Similar to hyperadrenergic state | ||
*Severe toxicity | *Severe toxicity accompanied by coma, seizure, bradycardia, hypotension, worsening hyperthermia | ||
== | ==Differential Diagnosis== | ||
#Intoxications | #Intoxications | ||
##Amphetamines | ##Amphetamines | ||
##Antimuscarinics | |||
#Withdrawal states | #Withdrawal states | ||
## | ##Ethanol | ||
##Clonidine | |||
##Beta-blockers | |||
#Medical conditions | #Medical conditions | ||
##Heat stroke | ##Heat stroke | ||
##Hypoglycemia | |||
##Hyperthyroidism | |||
#Adverse drug reactions | #Adverse drug reactions | ||
##[[Malignant Hyperthermia]] | ##[[Malignant Hyperthermia]] | ||
| Line 24: | Line 29: | ||
==Treatment== | ==Treatment== | ||
#Gastric decontamination | #Gastric decontamination | ||
## | ##Lavage indicated if can be performed <1 hour after ingestion | ||
##Activated charcoal | ##Activated charcoal x 1 | ||
#Supportive care | #Supportive care | ||
##Hypertension | ##Hypertension | ||
###Treat only with short-acting agents | ###Treat only with short-acting agents: may develop precipitous hypotension | ||
###Phentolamine | ###Phentolamine: 2.5-5mg IV bolus q15-15min; can also give as infusion 0.2-0.5mg/min | ||
###Nitroprusside: 1mcg/kg/min and titrate up | |||
###Nitroprusside | ##Hypotension: intravenous fluid / +/- norepinephrine | ||
##Seizures: benzodiazepines are 1st line | |||
##Hypotension | |||
##Seizures | |||
##Hyperthermia | ##Hyperthermia | ||
###Routine cooling measures | ###Routine cooling measures | ||
###Consider paralysis if | ###Consider paralysis if patient has persistent muscle rigidity | ||
==Disposition== | ==Disposition== | ||
*Admit all | *Admit all patients for 24 hour obsservation | ||
==Prevention== | ==Prevention== | ||
*Do not prescribe the following medications if a | *Do not prescribe the following medications if a patient is taking a MAOI: meperidine, dextromethorphan, tramadol, propoxyphene, or cyclobenzaprine | ||
==See Also== | ==See Also== | ||
Revision as of 02:43, 23 August 2013
Background
- Mono Amine Oxidase Inhibitors
- Used to treat depression and Parkinsonism (e.g. selegiline)
- Lead to increased norepinephrine, serotonin, dopamine, tyramine
- Toxicity often delayed 6-24 hours after ingestion
Clinical Features of Overdose
- Similar to hyperadrenergic state
- Severe toxicity accompanied by coma, seizure, bradycardia, hypotension, worsening hyperthermia
Differential Diagnosis
- Intoxications
- Amphetamines
- Antimuscarinics
- Withdrawal states
- Ethanol
- Clonidine
- Beta-blockers
- Medical conditions
- Heat stroke
- Hypoglycemia
- Hyperthyroidism
- Adverse drug reactions
Treatment
- Gastric decontamination
- Lavage indicated if can be performed <1 hour after ingestion
- Activated charcoal x 1
- Supportive care
- Hypertension
- Treat only with short-acting agents: may develop precipitous hypotension
- Phentolamine: 2.5-5mg IV bolus q15-15min; can also give as infusion 0.2-0.5mg/min
- Nitroprusside: 1mcg/kg/min and titrate up
- Hypotension: intravenous fluid / +/- norepinephrine
- Seizures: benzodiazepines are 1st line
- Hyperthermia
- Routine cooling measures
- Consider paralysis if patient has persistent muscle rigidity
- Hypertension
Disposition
- Admit all patients for 24 hour obsservation
Prevention
- Do not prescribe the following medications if a patient is taking a MAOI: meperidine, dextromethorphan, tramadol, propoxyphene, or cyclobenzaprine
See Also
Source
- Tintinalli
